The European Commission (EC) has granted marketing authorization for Eli Lilly’s Kisunla (donanemab) for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback